Relentless Health Value

Gary is a disrupter and founder of OM Healthcare, Inc. a health care technology startup established in 2015. He has over 18 years of business development experience and over 13 years of executive-level hospital and health system strategy expertise. Gary is a thought leader in the new frontier of health care technology, innovation, and strategy. Over the years Mr. Frazier's leadership and expertise has been sought after for strategic business planning, financial planning, growth strategy, integrated delivery systems, program development, mergers and acquisitions, and physician alignment. His roles have encompassed the rapid growth of Paladin Healthcare through hospital mergers and acquisitions, most notably a $170M acquisition of 2 Tenet hospitals in Philadelphia, PA. He served as a Principal for Vizient Consulting where he focused on physician/hospital alignment and hospital growth strategies for health systems throughout the United States. He was Vice President of Strategy and Business Development for a flagship 434-bed Dignity Health hospital in Central California where he was responsible for all strategy, growth, marketing, physician alignment, payer relations, and strategic partnerships. Before Dignity Health he managed all business development activities for hospital real estate transactions, expansions, and joint ventures in Arizona, California, and Nevada for Hammes Company Healthcare. A native of Southern California, he earned an undergraduate degree from Cal State Dominguez Hills and an MBA from UC Irvine Paul Merage School of Business. He has served as a board member of the California Hospital Association Political Action Committee (CHPAC), the Bakersfield March of Dimes, and the American Heart Association in Central California, and was Chairman of the Bakersfield Museum of Art. You can learn more at www.omhealthcare.com.

Stacey is co-president/CEO of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. Dave is co-president/CEO of Aventria Health Group and president/CEO of Pinnacle Health Communications. He is a 27-year veteran of managed-markets marketing. After working in consumer marketing with AT&T and health care publishing with Elsevier, Dave made the move to medical advertising and communications at KI Lipton, Inc. Subsequently, he became a cofounder of Pinnacle. Dave is an accomplished strategist, providing innovative customer marketing, access, quality, and health intervention solutions for large clients and has directed the development of numerous industry-leading campaigns in primary care and specialty markets. He has supported clients in disease areas that include oncology (Bristol Myers Squibb [BMS], Novartis, Eisai), virology (BMS, Merck & Co.), pharmacy (American Pharmacists Association, Merck, Novartis), and blood disorders (Novo Nordisk), to name a few. Dave has helped more than 15 clients achieve top rankings in their respective categories. He is also an active member of the Pharmacy Quality Alliance. You can learn more about Aventria Health Group at aventriahealth.com or by emailing david.dierk@aventriahealth.com.

Tim Thomas, RPh president, Crystal Clear Rx Mr. Thomas is a graduate of the University of South Carolina College of Pharmacy, and has 38 years' experience as a pharmacist. His management background includes residency training and being a Director of Pharmacy at both a hospital and an HMO. For the last 25 years Mr. Thomas has been involved in managed care pharmacy with expertise in formulary, benefit design, and creating value in the pharmacy benefit. He developed a PBM in the 1990’s and has held senior positions within the PBM industry. In 2008 he created Crystal Clear Rx, a pharmacy benefit consulting and research firm that is singularly focused on helping clients realize better value from their pharmacy benefit by providing optics into the PBM contracting process, data analysis, and cost effective solutions. You can learn more at www.crystalclearrx.com.

Juan Pablo founded Babyscripts in 2014 with the vision that internet - enabled medical devices would transform the delivery of pregnancy care. Since 2014, Juan Pablo has been named a Healthcare Transformer by the Startup Health Academy in New York and a Wireless Lifechanger by CTIA for his work in detecting problems in pregnancy faster. Juan Pablo is also the architect of the first "Prenatal Care Moonshot" focused on eliminating preterm birth by 2027 through mobile/digital technology and Babyscripts has been named Champions of Change in Precision Medicine by Barack Obama and the White House. Juan Pablo has raised $8.6 million in venture/angel financing for furthering his vision of a data centric model in prenatal care which includes the recent closure of a Series A of $5.5 million. He has orchestrated large partnerships with General Electric and their Healthymagination initiative and the March of Dimes specifically targeting the elimination of premature birth. He has also led the Babyscripts sales team, closing large hospital deals with more than 13 health systems around the country and successfully signing a co-development deal to build an at-risk product with Aurora Health Care in Wisconsin. Juan Pablo is a frequent speaker on the future of health care. He has spoken at the mHealth Summit on "How to Demonstrate Value in Digital/Mobile Health," at the national HIMSS conference on "Establishing ROI and Forming Partnerships: Digital Health Dating," and at the Bio+Tech conference on "Collaborating for Patient Engagement." He has pitched and won Startup Competitions at SXSW at their Barracuda Bowl and the 1776 Healthcare Challenge Cup. He has also been invited to share his thoughts on podcasts and write op-ed articles on startup fundraising and the future of health care. He was recently interviewed by Medistrategy and wrote "3 Musts for Raising Your First Round" and "Why Disruption in Health IT is like a Tiramisu Cake."

Jennifer E. Miller, PhD, is an Assistant Professor at the NYU School of Medicine and President of the nonprofit, Bioethics International. She is also the Creator of the Good Pharma Scorecard, an index that ranks all new drugs and large pharmaceutical companies on their ethics and public health performance to help recognize good practices in companies, improve trustworthiness, and incentivize change where needed.  Prior to joining NYU, Dr. Miller was based at Harvard University. Dr. Miller currently serves on NYU’s Pharmacy and Therapeutics Committee and Stem Cell Research Oversight IRB, as well as the J&J-NYU Compassionate-Use Advisory Committee (monitor). Previously, she served on the Center for Disease Control and Prevention’s (CDC) Task Force for Pediatric Emergency Mass Critical Care, the American Medical Association’s (AMA) Advanced Disaster Life Support Education Consortium, as a consultant to the United Nations Economic and Social Council, and on the PCORI-NIH Collaboratory. A prolific writer, Dr. Miller has authored over 35 articles in publications including Nature Medicine and Health Affairs. She was a Fox News pundit from 2009 to 2012 and remains a news commentator, frequently featured on CBS news, Wall Street Journal, Washington Post, Bloomberg News, Forbes, and NPR. Dr. Miller’s current work explores the ethics and governance of new drugs that are researched, developed, marketed, priced, and made accessible to patients globally. She also specializes in the ethics of data sharing. 00:00 EP148: Jennifer E. Miller, PhD, Bioethics International and Creator of the Good Pharma Scorecard. 01:00 The Good Pharma Scorecard rankings for 2017. 01:40 Two 100% transparent pharma companies. 02:20 Two stats that prove that Pharma companies are improving. 03:00 Industry improvements on patient trials. 03:25 Ninety-six percent of all patient trials are available to the public. 03:45 Where there wasn’t a significant improvement in disclosure in pharma.

Dr. Kyra Bobinet has five words of advice on engaging people in health: be caring, authentic, and useful. As a national speaker, bestselling author and CEO-founder of engagedIN, a neuroscience behavior design firm, Kyra devotes her life to cracking the code of WHY we engage in our health. Everyday, she and her team use neuroscience to make products and communications more engaging. For this work, Kyra received the 2015 Innovator Award from Harvard where she received her Masters in Public Health. She earned her medical degree at UCSF School of Medicine. Dr. Bobinet is the author of Well Designed Life: 10 Lessons in Brain Science and Design Thinking for a Mindful, Healthy, and Purposeful Life. She has been featured by the Wall Street Journal, New York Times, Huffington Post, ExperienceLife and NPR. She has created health start-ups, blockbuster products, health apps, big data algorithms, and evidence-based programs in mind-body & metabolic medicine. A former executive at a large payer, she has designed large-scale population health management and wellness interventions that yielded ROI for Fortune 500 companies. Dr. Bobinet co-teaches patient engagement and health design with Dr. Larry Chu at Stanford School of Medicine, and studied in BJ Fogg’s behavior design lab. When she’s not geeking out on neuroscience, you can find her engaged in her 160-acre training center in the Santa Cruz Mountains. You can learn more at engagedin.com and changetrainingcenter.com.

Stacey is co-president of Aventria Health Group, specializing in helping employer, pharmaceutical, device, and pharmacy clients by creating partnerships with other health care organizations. For 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and most of all, the patient. 00:00 The state of health care is fragile. 00:45 Antifragile: Things That Gain from Disorder by Nassim Nicholas 02:20 How easy it is for healthcare systems to break down. 02:40 “You can’t domesticate disorder, volatility, or uncertainty.” 03:15 The requirements of being an antifragile organization. 03:30 “Does everyone on the team understand the end game?” 04:45 Balancing people and processes. 05:25 “There is always judgement involved.” 06:30 Overlap and quality control. 09:10 Allow for small mistakes. 11:45 The need for a feedback group. 14:15 Iatrogenic - relating to an illness caused by medical examination or treatment. 15:20 How rapid scaling slows down the ability to become antifragile. 17:10 Testing if you’re doing something for the wrong reasons. 18:00 “What does the healthy business look like?” 18:20 How oligopolies make health care more fragile.

Ross Bjella, MBA is the founder and CEO of Alithias, a patient advocacy and population health analytics company serving self-insured employers, insurance companies, networks, and third party administrators.  “Alithias” means “the truth” in Greek and currently has >60,000 lives with access to the platform.  Ross has held senior management positions in the health care industry, including pharmaceuticals, biotech, and medical devices. Prior to Alithias, Ross served as the CEO of DDN, a leading business process outsourcer for pharma and biotech companies. Ross still consults with pharma companies about 3PL selection and resolving and supply chain issues from time to time.  He has a degree in Biology from the University of Minnesota and a MBA from the University of Southern California. You can learn more at alithias.com or by emailing Ross at ross@alithias.com, or following Ross on twitter @rossbjella.

Pramod John is team leader of Vivio Health, a company that is reinventing the therapeutic use and supply chain for the specialty drug space. The Vivio Health plan solution is challenging the current framework of efficacy and extending it to true effectiveness in the real world. It also offers significant drug acquisition savings and simplicity for the patient by integrating the supply chain into a unified and data driven process. Prior to Vivio Health, Pramod was founder of Oration PBC (acquired by PokitDok) which was focused on giving back consumers control over their drug purchasing by capturing the prescription in the physician’s office and providing real-time pricing options and automatic routing capabilities. Pramod was also VP of Strategy and Innovation at McKesson, the world’s largest health care company. At McKesson, Pramod helped develop solutions that leveraged advanced technologies and business process improvements to optimize health care delivery systems, infrastructure, and supply chains. Earlier, Pramod founded and served as CEO of PacketMotion, Inc., a venture-funded startup in the enterprise network information and policy management industry. The company was later acquired by VMware. In addition, Pramod founded netExaminer.com, a managed-vulnerability assessment company acquired by SonicWALL (owned by Dell). Pramod earned his PhD in Electrical Engineering from the University of Illinois at Urbana-Champaign. He serves on the Boards of Mission Aviation Fellowship, a global relief organization, and 3Crosses Church in Castro Valley, CA. He also serves on the advisory board of Folia Water and as a mentor at StartX. You can learn more at www.viviohealth.com.

Erik serves as a Managing Director in the Accenture Health Client Service Group where he manages a large team of healthcare professionals within the Clinical and Health Management Services team. He serves as the Managing Director for Healthcare Provider Technology Consulting in North America, as well as Accenture's Blockchain lead across the healthcare service line and as a co-lead of Accenture's Value Based Care practice in North America. In his role, he partners with senior client executives to develop and drive healthcare transformation strategies, guide healthcare investment decisions, develop innovation roadmaps for new use of health IT, and build transformation programs in support of population health, care management, value based care, and interoperability initiatives. He also has extensive responsibilities for a diverse portfolio of sales and business development activities at major Accenture healthcare clients and leads a wide range of provider and payer sales opportunities across North America. Erik has worked for over 20 years in healthcare, including senior positions in federal, state, and commercial healthcare programs and initiatives, and served in key leadership roles within the healthcare community. He holds leadership advisory positions within the American Health Information Management Association (AHIMA), the Healthcare Information and Management Systems Society (HIMSS), and the Healthcare Financial Management Association (HFMA), and regularly speaks at industry conferences on trends influencing the healthcare industry. He received a certification as a Certified Professional in Healthcare Information & Management Systems (CHPIMS) in 2009 and became a HIMSS Fellow in 2012. You can learn more at accenture.com.